Stimart Tryn 4
4 · AbCellera Biologics Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Stimart Tryn
Chief Legal Officer
Transactions
- Award
Share option (right to buy)
2025-01-01+832,033→ 4,106,747 totalExercise: $2.93Exp: 2035-01-01→ Common Shares (832,033 underlying)
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.